Maternal Valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: Maternal and neonatal outcome

Marco De Santis; C. De Luca; Massimo Apicella; L. D'Oria; Antonio Lanzone; Maurizio Sanguinetti; Piero Valentini; Giovanni Scambia; Lucia Masini; Rosaria Santangelo

doi:10.1016/j.reprotox.2020.04.005

Maternal Valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: Maternal and neonatal outcome

Marco De Santis, C. De Luca, Massimo Apicella, L. D'Oria, Antonio Lanzone, Maurizio Sanguinetti, Piero Valentini, Giovanni Scambia, Lucia Masini, Rosaria Santangelo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Naproxen is one of the less frequently used nonsteroidal anti-inflammatory drugs (NSAIDs) in Germany. Data on pregnancy outcomes in women exposed to naproxen are inconsistent. The objective of this study was to assess the risk of exposure to naproxen in the first trimester of pregnancy.

Lingua originale	English
pagine (da-a)	1-2
Numero di pagine	2
Rivista	Reproductive Toxicology
Volume	97
DOI	https://doi.org/10.1016/j.reprotox.2020.04.005
Stato di pubblicazione	Pubblicato - 2020

Keywords

inglese

Accesso al documento

10.1016/j.reprotox.2020.04.005

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{de9a2ea9c37342e5a00838f7e2bc7e17,

title = "Maternal Valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: Maternal and neonatal outcome",

abstract = "Naproxen is one of the less frequently used nonsteroidal anti-inflammatory drugs (NSAIDs) in Germany. Data on pregnancy outcomes in women exposed to naproxen are inconsistent. The objective of this study was to assess the risk of exposure to naproxen in the first trimester of pregnancy.",

keywords = "inglese, inglese",

author = "{De Santis}, Marco and {De Luca}, C. and Massimo Apicella and L. D'Oria and Antonio Lanzone and Maurizio Sanguinetti and Piero Valentini and Giovanni Scambia and Lucia Masini and Rosaria Santangelo",

year = "2020",

doi = "10.1016/j.reprotox.2020.04.005",

language = "English",

volume = "97",

pages = "1--2",

journal = "Reproductive Toxicology",

issn = "0890-6238",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Maternal Valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: Maternal and neonatal outcome

AU - De Santis, Marco

AU - De Luca, C.

AU - Apicella, Massimo

AU - D'Oria, L.

AU - Lanzone, Antonio

AU - Sanguinetti, Maurizio

AU - Valentini, Piero

AU - Scambia, Giovanni

AU - Masini, Lucia

AU - Santangelo, Rosaria

PY - 2020

Y1 - 2020

N2 - Naproxen is one of the less frequently used nonsteroidal anti-inflammatory drugs (NSAIDs) in Germany. Data on pregnancy outcomes in women exposed to naproxen are inconsistent. The objective of this study was to assess the risk of exposure to naproxen in the first trimester of pregnancy.

AB - Naproxen is one of the less frequently used nonsteroidal anti-inflammatory drugs (NSAIDs) in Germany. Data on pregnancy outcomes in women exposed to naproxen are inconsistent. The objective of this study was to assess the risk of exposure to naproxen in the first trimester of pregnancy.

KW - inglese

UR - http://hdl.handle.net/10807/167138

U2 - 10.1016/j.reprotox.2020.04.005

DO - 10.1016/j.reprotox.2020.04.005

M3 - Article

SN - 0890-6238

VL - 97

SP - 1

EP - 2

JO - Reproductive Toxicology

JF - Reproductive Toxicology

ER -

Maternal Valacyclovir treatment in fetal CMV infection from amniocentesis until delivery: Maternal and neonatal outcome

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo